Luokung Technology (NASDAQ:LKCO) reported $62.81 million in sales this quarter. This is a 66.05 percent increase over sales of $37.83 million the same period last year.
Piper Sandler Downgrades Abiomed to Neutral, Raises Price Target to $380
Piper Sandler analyst Matt O'Brien downgrades Abiomed (NASDAQ:ABMD) from Overweight to Neutral and raises the price target from $350 to $380.